Business Segments · Foreign currency translation adjustments, net
Oncology & Multispecialty — Foreign currency translation adjustments, net
Analysis
StatementSegment
CategoryRisk
SignalContext dependent
VolatilityVolatile
First reportedQ1 2025
Last reportedQ4 2026May 8, 2026
Rolls up toFX & Other Adjustments
How to read this metric
Negative values indicate a strengthening reporting currency, while positive values indicate a weakening reporting currency relative to international operations.
Detailed definition
The net impact of fluctuations in foreign exchange rates on the valuation of assets and liabilities denominated in curre...
Peer comparison
Standard line item for multinational corporations with significant non-domestic revenue.
Metric ID:
mck_segment_oncology_multispecialty_foreign_currency_translation_adjustments_netHistorical Data
6 periods
| Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q3 '26 | Q4 '26 | |
|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Range$0.00 – $0.00
Similar Metrics at Other Companies
Frequently Asked Questions
- What is McKesson's oncology & multispecialty — foreign currency translation adjustments, net?
- McKesson (MCK) reported oncology & multispecialty — foreign currency translation adjustments, net of $0.00 in Q1 2026.
- What does oncology & multispecialty — foreign currency translation adjustments, net mean?
- Gains or losses caused by changes in currency exchange rates.